Skip to content
10-Q

Quarterly Report

NUTRA PHARMA CORP. NPHC

0001493152-25-019037

← back to feed
Filed
Oct 23, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Oct 23, 2025 7.1B sh
Short Term Debt Q2 2023 · Jun 30, 2023 $8.19M
Short Term Debt Q2 2023 · Dec 31, 2022 $7.93M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $0
Cash And Equivalents Q2 2023 · Dec 31, 2022 $0
Current Liabilities Q2 2023 · Jun 30, 2023 $13.65M
Current Liabilities Q2 2023 · Dec 31, 2022 $12.7M
Total Liabilities Q2 2023 · Jun 30, 2023 $14M
Total Liabilities Q2 2023 · Dec 31, 2022 $13.13M
Current Assets Q2 2023 · Jun 30, 2023 $375.7K
Current Assets Q2 2023 · Dec 31, 2022 $333.58K
Total Assets Q2 2023 · Jun 30, 2023 $748.18K
Total Assets Q2 2023 · Dec 31, 2022 $754.91K
Shares Diluted Q2 2023 · Jun 30, 2022 7.47B sh
Shares Diluted Q2 2023 · Jun 30, 2022 15.46B sh
Capex Q2 2023 · Jun 30, 2022 $57.99K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$543.06K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$16.2M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$15.77M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$20.88M
Eps Diluted Q2 2023 · Jun 30, 2022 $0.00
Eps Diluted Q2 2023 · Jun 30, 2022 $0.00
Eps Basic Q2 2023 · Jun 30, 2022 $0.00
Eps Basic Q2 2023 · Jun 30, 2022 $0.00
Sga Expense Q2 2023 · Jun 30, 2022 $348.87K
Sga Expense Q2 2023 · Jun 30, 2022 $665.08K
Net Income Q2 2023 · Jun 30, 2022 −$645.8K
Net Income Q2 2023 · Jun 30, 2022 $4.37M
Operating Income Q2 2023 · Jun 30, 2022 −$341.09K
Operating Income Q2 2023 · Jun 30, 2022 −$649.51K
Gross Profit Q2 2023 · Jun 30, 2022 $29.58K
Gross Profit Q2 2023 · Jun 30, 2022 $37.37K
Revenue restated Q2 2023 · Jun 30, 2022 $28.43K
Revenue restated Q2 2023 · Jun 30, 2022 $42.19K